Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   
X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

Carney complex (CNC)

Written2004-08Constantine A Stratakis, Ludmila Matyakhina
Unit on Genetics &Endocrinology (UGEN), DEB, NICHD, NIH, Building 10, Room 10N262, 10 Center Drive, MSC 1862, Bethesda, MD 20892-1862, USA

(Note : for Links provided by Atlas : click)
 

Identity

Atlas_Id 10080
Genes implicated inCNC2   PRKAR1A  
Note A multiple neoplasia syndrome characterized by spotty skin pigmentation, cardiac and other myxomas, endocrine tumors, psammomatous melanotic schwannomas and other tumors.
Inheritance A genetically heterogeneous autosomal dominant disorder with high penetrance for CNC1 (penetrance for CNC1 due to PRKARIA defects is close to 100%); this estimate of penetrance does not apply to kindreds with CNC2 because the CNC2 gene (s) is still unknown. Most of the cases of CNC (70%) are familial.

Clinics

Phenotype and clinics Developmental disorder. In some cases the disease is diagnosed at birth. Onset of the disease occurs commonly at a young age and the median age at detection is 20 years.

Spotty skin pigmentation lesions, such as lentigines (small, brown to black, non or slightly elevated, round or irregular) and blue nevi (large, blue to black, domed lesion) observed primarily in the face, eyelids, ears, and borders of the lips are the most common clinical manifestation of CNC (77%). Lentigines tend to fade with the age, usually after the fourth decade of life.

Myxomas are frequent lesions in CNC patients; heart myxomas (53%) occur multicentrically, and in any, or all, cardiac chambers; skin myxomas (33%) are detected in the eyelid, the external ear canal, the nipple, the oropharynx, the female genital tract and the female pelvis. Breast myxomas are often bilateral and present in more than 70% of adult women with CNC.

Psammomatous melanotic shwannomas , very rare tumors (10%), may occur anywhere in the peripheral nervous system, but most frequently in the gastrointestinal tract and paraspinal symphatetic chain.

Breast ductal adenomas, unusual mammary tumors akin to intraductal papillomas have been detected in 3% of CNC cases.

Endocrine lesions in CNC include testicular neoplasms (33%), primary pigmented nodule adrenocortical disease (PPNAD) (26%), growth hormone (GH) and prolactin-producing pituitary tumors (14%) and thyroid cancer (5%).

Neoplastic risk
  • Skin lesions are benign.
  • Heart, skin and breast myxomas are benign lesions.
  • Psammomatous melanotic shwannoma may be malignant and metastasizes aggressively to lungs, brain and other organs
  • Breast ductal adenomas are benign but malignancy was detected in one case
  • Testicular tumors are almost always benign; metastasis has been reported only in one older patient.
  • PPNAD in CNC is always benign.
  • Growth hormone and prolactin-producing pituitary tumors are benign lesions.
  • Thyroid neoplasms may also become malignant.
    • Treatment Annual studies: echocardiogram (note that in pediatric patients it should be done during the first 6 months of life and annually thereafter), measurement of urinary free cortisol and serum IGF-1 levels, thyroid ultrasonography, testicular ultrasonography for male and transabdominal pelvic ultrasonography for females; surgery when necessary. Additional clinical and imaging studies may be necessary for the detection of PPNAD and GH-producing pituitary adenoma.
    Prognosis According to the severity of the disease in a given patient, and to the quality of a regular follow up, life span is decreased in patients with CNC. 57% of the deaths are due to heart related causes; others due to the postoperative complications or evolution of the maligant process; a presymptomatic diagnosis improves survival data and might prevent earlier the main causes of death in this disease.

    Genes involved and Proteins

    Gene NamePRKAR1A (protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1))
    Alias CAR CNC1 MGC17251 PKR1 PRKAR1 TSE1
    Location 17q24.2 17q23-24
    Note Mutations in PRKARIA are found in about 46 % of cases of CNC syndrome; there is genetic heterogeneity, and unknown gene(s) on 2p16 is probably also responsible for the disease.
    DNA/RNA
    Description 10 exons
    Protein
    Description 48 kDa; contains two tandem cAMP-binding domains at the C-terminus and the dimerization domain at the N-terminus that serves also as a docking site for A Kinase Anchoring Proteins (AKAPs).
    Expression Ubiquitously expressed, in particular in brain, endocrine tissues, adipose tissue and bone.
    Function The function of PRKAR1A is to bind cAMP and regulate the function of the catalytic subunits of the protein kinase A (PKA) holoenzyme. Two regulatory subunits bind two catalytic subunits forming an inactive PKA tetramer. Activation of PKA occurs when 2 cAMP molecules bind to each regulatory subunit eliciting a reversible conformational change that releases active catalytic subunits. Four different regulatory subunits and three catalytic subunits of PKA have been identified in humans. The protein encoded by this gene is one of the regulatory subunits. It may act as a tumor-suppressor in CNC and other tumors.
    Mutations
    Germinal Most mutations are null alleles; they are dispersed through the coding region of the gene, involving every exon except 4A, 9 and 10.
    Somatic Many of CNC tumors show loss of heterozygosity.

    Gene NameCNC2 (Carney complex type 2, multiple neoplasia and lentiginosis)
    Location 2p16
    DNA/RNA
    Description Unknown
    Protein
    Function Unknown
    Mutations
    Somatic Many of CNC tumors show amplification or deletion of the 2p16 region.

    Bibliography

    A syndrome of various cutaneous pigmented lesions, myxoid neurofibromata and atrial myxoma: the NAME syndrome.
    Atherton DJ, Pitcher DW, Wells RS, MacDonald DM
    The British journal of dermatology. 1980 ; 103 (4) : 421-429.
    PMID 7437308
     
    Carney's complex.
    Bain J
    Mayo Clinic proceedings. Mayo Clinic. 1986 ; 61 (6) : page 508.
    PMID 3713260
     
    Genetic heterogeneity of familial atrial myxoma syndromes (Carney complex).
    Basson CT, MacRae CA, Korf B, Merliss A
    The American journal of cardiology. 1997 ; 79 (7) : 994-995.
    PMID 9104925
     
    The search for Harvey Cushing's patient, Minnie G., and the cause of her hypercortisolism.
    Carney JA
    The American journal of surgical pathology. 1995 ; 19 (1) : 100-108.
    PMID 7802129
     
    Osteochondromyxoma of bone: a congenital tumor associated with lentigines and other unusual disorders.
    Carney JA, Boccon-Gibod L, Jarka DE, Tanaka Y, Swee RG, Unni KK, Stratakis CA
    The American journal of surgical pathology. 2001 ; 25 (2) : 164-176.
    PMID 11176065
     
    The complex of myxomas, spotty pigmentation, and endocrine overactivity.
    Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL
    Medicine. 1985 ; 64 (4) : 270-283.
    PMID 4010501
     
    Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity.
    Carney JA, Hruska LS, Beauchamp GD, Gordon H
    Mayo Clinic proceedings. Mayo Clinic. 1986 ; 61 (3) : 165-172.
    PMID 3945116
     
    Epithelioid blue nevus and psammomatous melanotic schwannoma: the unusual pigmented skin tumors of the Carney complex.
    Carney JA, Stratakis CA
    Seminars in diagnostic pathology. 1998 ; 15 (3) : 216-224.
    PMID 9711672
     
    Identification of a novel genetic locus for familial cardiac myxomas and Carney complex.
    Casey M, Mah C, Merliss AD, Kirschner LS, Taymans SE, Denio AE, Korf B, Irvine AD, Hughes A, Carney JA, Stratakis CA, Basson CT
    Circulation. 1998 ; 98 (23) : 2560-2566.
    PMID 9843463
     
    Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome.
    Cuttler L, Jackson JA, Saeed uz-Zafar M, Levitsky LL, Mellinger RC, Frohman LA
    The Journal of clinical endocrinology and metabolism. 1989 ; 68 (6) : 1148-1154.
    PMID 2498385
     
    Sporadic cardiac myxomas and tumors from patients with Carney complex are not associated with activating mutations of the Gs alpha gene.
    DeMarco L, Stratakis CA, Boson WL, Jakbovitz O, Carson E, Andrade LM, Amaral VF, Rocha JL, Choursos GP, Nordenskjöld M, Friedman E
    Human genetics. 1996 ; 98 (2) : 185-188.
    PMID 8698339
     
    Multiple lentigines associated with cutaneous myxomas.
    Egan CA, Stratakis CA, Turner ML
    Journal of the American Academy of Dermatology. 2001 ; 44 (2) : 282-284.
    PMID 11174387
     
    Acromegaly and hyperprolactinemia in a patient with polyostotic fibrous dysplasia: dynamic endocrine studies and treatment with the somatostatin analogue octreotide.
    Garcia MB, Koppeschaar HP, Lips CJ, Thijssen JH, Krenning EP
    Journal of endocrinological investigation. 1994 ; 17 (1) : 59-65.
    PMID 7911814
     
    Molecular genetic diagnosis of the familial myxoma syndrome (Carney complex).
    Goldstein MM, Casey M, Carney JA, Basson CT
    American journal of medical genetics. 1999 ; 86 (1) : 62-65.
    PMID 10440831
     
    Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD.
    Groussin L, Kirschner LS, Vincent-Dejean C, Perlemoine K, Jullian E, Delemer B, Zacharieva S, Pignatelli D, Carney JA, Luton JP, Bertagna X, Stratakis CA, Bertherat J
    American journal of human genetics. 2002 ; 71 (6) : 1433-1442.
    PMID 12424709
     
    Multiple lentigines, myxoid tumours and endocrine overactivity; four cases of Carney's complex.
    Handley J, Carson D, Sloan J, Walsh M, Thornton C, Hadden D, Bingham EA
    The British journal of dermatology. 1992 ; 126 (4) : 367-371.
    PMID 1571257
     
    Evidence for a second genetic locus in Carney complex.
    Irvine AD, Armstrong DK, Bingham EA, Hadden DR, Nevin NC, Hughes AE
    The British journal of dermatology. 1998 ; 139 (4) : 572-576.
    PMID 9892898
     
    Ocular pigmented spots and eyelid myxomas.
    Kennedy RH, Waller RR, Carney JA
    American journal of ophthalmology. 1987 ; 104 (5) : 533-538.
    PMID 3674187
     
    Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex.
    Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA, Stratakis CA
    Human molecular genetics. 2000 ; 9 (20) : 3037-3046.
    PMID 11115848
     
    Autosomal dominant transmission of the NAME syndrome (nevi, atrial myxoma, mucinosis of the skin and endocrine overactivity).
    Koopman RJ, Happle R
    Human genetics. 1991 ; 86 (3) : 300-304.
    PMID 1997386
     
    Pituitary adenoma in Carney complex: an immunohistochemical, ultrastructural, and immunoelectron microscopic study.
    Kurtkaya-Yapicier O, Scheithauer BW, Carney JA, Kovacs K, Horvath E, Stratakis CA, Vidal S, Vella A, Young WF Jr, Atkinson JL, Lloyd RV, Kontogeorgos G
    Ultrastructural pathology. 2002 ; 26 (6) : 345-353.
    PMID 12537759
     
    Syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney complex).
    Legius E, Daenen W, Vandenbergh V, Verbeeck G, Bex M, Fryns JP
    Genetic counseling (Geneva, Switzerland). 1998 ; 9 (4) : 287-290.
    PMID 9894167
     
    Chromosome 2 (2p16) abnormalities in Carney complex tumours.
    Matyakhina L, Pack S, Kirschner LS, Pak E, Mannan P, Jaikumar J, Taymans SE, Sandrini F, Carney JA, Stratakis CA
    Journal of medical genetics. 2003 ; 40 (4) : 268-277.
    PMID 12676898
     
    Spectrum of malignancy and premalignancy in Carney syndrome.
    Nwokoro NA, Korytkowski MT, Rose S, Gorin MB, Penles Stadler M, Witchel SF, Mulvihill JJ
    American journal of medical genetics. 1997 ; 73 (4) : 369-377.
    PMID 9415461
     
    Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas (Carney complex).
    Pack SD, Kirschner LS, Pak E, Zhuang Z, Carney JA, Stratakis CA
    The Journal of clinical endocrinology and metabolism. 2000 ; 85 (10) : 3860-3865.
    PMID 11061550
     
    Ovarian tumors associated with multiple endocrine neoplasias and related syndromes (Carney complex, Peutz-Jeghers syndrome, von Hippel-Lindau disease, Cowden's disease).
    Papageorgiou T, Stratakis CA
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2002 ; 12 (4) : 337-347.
    PMID 12144681
     
    Testicular ultrasound in Carney complex: report of three cases.
    Premkumar A, Stratakis CA, Shawker TH, Papanicolaou DA, Chrousos GP
    Journal of clinical ultrasound : JCU. 1997 ; 25 (4) : 211-214.
    PMID 9142622
     
    Large-cell calcifying Sertoli cell tumor of the testis.
    Proppe KH, Scully RE
    American journal of clinical pathology. 1980 ; 74 (5) : 607-619.
    PMID 7446466
     
    Prolactin secretion abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas (Carney complex).
    Raff SB, Carney JA, Krugman D, Doppman JL, Stratakis CA
    Journal of pediatric endocrinology & metabolism : JPEM. 2000 ; 13 (4) : 373-379.
    PMID 10776991
     
    Lentiginosis and left atrial myxoma.
    Rees JR, Ross FG, Keen G
    British heart journal. 1973 ; 35 (8) : 874-876.
    PMID 4729862
     
    Mucocutaneous lentigines, cardiomucocutaneous myxomas, and multiple blue nevi: the LAMB syndrome.
    Rhodes AR, Silverman RA, Harrist TJ, Perez-Atayde AR
    Journal of the American Academy of Dermatology. 1984 ; 10 (1) : 72-82.
    PMID 6693605
     
    Clinical and molecular genetics of Carney complex.
    Sandrini F, Stratakis C
    Molecular genetics and metabolism. 2003 ; 78 (2) : 83-92.
    PMID 12666684
     
    Primary pigmented nodular adrenocortical disease: reevaluation of a patient with carney complex 27 years after unilateral adrenalectomy.
    Sarlis NJ, Chrousos GP, Doppman JL, Carney JA, Stratakis CA
    The Journal of clinical endocrinology and metabolism. 1997 ; 82 (4) : 1274-1278.
    PMID 9100606
     
    Primary adrenocortical nodular dysplasia with Cushing's syndrome and cardiac myxomas. A peculiar familial disease.
    Schweizer-Cagianut M, Salomon F, Hedinger CE
    Virchows Archiv. A, Pathological anatomy and histology. 1982 ; 397 (2) : 183-192.
    PMID 7179736
     
    Bilateral primary pigmented nodular adrenocortical disease. Rare cause of the Cushing syndrome.
    Shenoy BV, Carpenter PC, Carney JA
    The American journal of surgical pathology. 1984 ; 8 (5) : 335-344.
    PMID 6329005
     
    Human tumors associated with Carney complex and germline PRKAR1A mutations: a protein kinase A disease!
    Stergiopoulos SG, Stratakis CA
    FEBS letters. 2003 ; 546 (1) : 59-64.
    PMID 12829237
     
    Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation.
    Stratakis CA, Kirschner LS, Carney JA
    The Journal of clinical endocrinology and metabolism. 2001 ; 86 (9) : 4041-4046.
    PMID 11549623
     
    Radiation hybrid mapping of chromosomal region 2p15-p16: integration of expressed and polymorphic sequences maps at the Carney complex (CNC) and Doyne honeycomb retinal dystrophy (DHRD) loci.
    Taymans SE, Kirschner LS, Giatzakis C, Stratakis CA
    Genomics. 1999 ; 56 (3) : 344-349.
    PMID 10087203
     
    Syndrome myxoma: a subset of patients with cardiac myxoma associated with pigmented skin lesions and peripheral and endocrine neoplasms.
    Vidaillet HJ Jr, Seward JB, Fyke FE 3rd, Su WP, Tajik AJ
    British heart journal. 1987 ; 57 (3) : 247-255.
    PMID 3566983
     
    Neurosurgical implications of Carney complex.
    Watson JC, Stratakis CA, Bryant-Greenwood PK, Koch CA, Kirschner LS, Nguyen T, Carney JA, Oldfield EH
    Journal of neurosurgery. 2000 ; 92 (3) : 413-418.
    PMID 10701527
     
    A familial syndrome of cardiac myxomas, myxoid neurofibromata, cutaneous pigmented lesions, and endocrine abnormalities.
    Wilsher ML, Roche AH, Neutze JM, Synek BJ, Holdaway IM, Nicholson GI
    Australian and New Zealand journal of medicine. 1986 ; 16 (3) : 393-396.
    PMID 3465316
     
    A typical Korean case of Carney complex.
    Yoon HD, Shon HS
    The Korean journal of internal medicine. 2003 ; 18 (4) : 260-265.
    PMID 14717239
     
    Familial Cushing's syndrome due to primary pigmented nodular adrenocortical disease. Reinvestigation 50 years later.
    Young WF Jr, Carney JA, Musa BU, Wulffraat NM, Lens JW, Drexhage HA
    The New England journal of medicine. 1989 ; 321 (24) : 1659-1664.
    PMID 2586567
     

    Citation

    This paper should be referenced as such :
    Stratakis, CA ; Matyakhina, L
    Carney complex (CNC)
    Atlas Genet Cytogenet Oncol Haematol. 2004;8(4):336-339.
    Free journal version : [ pdf ]   [ DOI ]
    On line version : http://AtlasGeneticsOncology.org/Tumors/CarneyComplexID10080.html

    Other genes implicated (Data extracted from papers in the Atlas) [ 3 ]

    Genes PRKAR1A PRKAR1A THRB

    REVIEW articlesautomatic search in PubMed
    Last year articlesautomatic search in PubMed


    © Atlas of Genetics and Cytogenetics in Oncology and Haematology
    indexed on : Mon Dec 14 18:29:40 CET 2020

    Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

    For comments and suggestions or contributions, please contact us

    jlhuret@AtlasGeneticsOncology.org.